Ascelis Center of Excellence for Peptide Development and Characterization will drive the development of cosmetic, therapeutic, and pharmaceutical peptides
Pharmaplan brings a pan-European footprint of locations and specialist teams, now operating within Exyte’s Biopharma & Life Sciences division
A key highlight will be Brenntag’s qualified amino acids portfolio
The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects
This new facility strengthens Latin America as a collaborative hub
The Court dismissed Swiss drugmaker Roche’s plea for interim injunction
Pfizer will participate in TrumpRx.gov, a direct-to-patient purchasing platform offering discount up to 85%
Expanded capabilities that continue to push the boundaries of innovation—advancing drug delivery solutions for patients, customers, and consumers around the world
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
The $700 million project is part of Roche’s $50 billion investment in US manufacturing, infrastructure and R&D
Subscribe To Our Newsletter & Stay Updated
